Watch for Acid-Reducer Interactions With New Hep C Med Harvoni
Please see new warnings concerning the use of amiodarone with Harvoni or Sovaldi
    You'll see two new ORAL hepatitis C regimens...Harvoni (har-VOE-nee) and Olysio (simeprevir) PLUS Sovaldi (sofosbuvir).   These new regimens are changing hep C therapy again...because they eliminate the need for ribavirin and interferon for most patients.
   Harvoni is a new once-daily tablet that combines Sovaldi with a new antiviral, ledipasvir.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote